Cheol Lee J, Hung JY, Kim YC, Chang GC, Soo Yoo S, Yang SH, Davis KL, Nagar SP, Taylor A, Yong Lee S, Shih JY. Real-world treatment patterns in patients with EGFR mutation-positive NSCLC receiving a first line, first- or second-generation EGFR tyrosine kinase inhibitor in South Korea and Taiwan. Asian Pac J Cancer Bio. 2021 May 20;6(2). doi: 10.31557/APJCB.2021.6.2.123-132
Freund DA, Hurley RE, Adamache KW, Mauskopf J. The performance of urban and public hospitals and NHCs (neighborhood health centers) under Medicaid capitation programs. Hosp Health Serv Adm. 1990 Jan 1;35(4):525-46.